Ingalls & Snyder LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.75M | Buy |
78,370
+148
| +0.2% | +$8.63K | 0.17% | 102 |
|
|
2025
Q4 | $4.22M | Sell |
78,222
-33,848
| -30% | -$1.63M | 0.15% | 104 |
|
|
2025
Q3 | $5.05M | Sell |
112,070
-7,696
| -6% | -$359K | 0.17% | 92 |
|
|
2025
Q2 | $5.54M | Sell |
119,766
-7,085
| -6% | -$348K | 0.2% | 82 |
|
|
2025
Q1 | $7.74M | Sell |
126,851
-5,826
| -4% | -$340K | 0.25% | 63 |
|
|
2024
Q4 | $7.5M | Sell |
132,677
-29,154
| -18% | -$1.63M | 0.29% | 64 |
|
|
2024
Q3 | $8.37M | Sell |
161,831
-31,505
| -16% | -$1.48M | 0.33% | 58 |
|
|
2024
Q2 | $8.03M | Sell |
193,336
-274,803
| -59% | -$12.3M | 0.35% | 54 |
|
|
2024
Q1 | $25.4M | Buy |
468,139
+36,072
| +8% | +$1.84M | 1.12% | 19 |
|
|
2023
Q4 | $22.2M | Sell |
432,067
-51,879
| -11% | -$2.72M | 1% | 23 |
|
|
2023
Q3 | $28.1M | Sell |
483,946
-5,105
| -1% | -$313K | 1.35% | 14 |
|
|
2023
Q2 | $31.3M | Buy |
489,051
+10,398
| +2% | +$697K | 1.5% | 13 |
|
|
2023
Q1 | $33.2M | Buy |
478,653
+17,032
| +4% | +$1.2M | 1.7% | 10 |
|
|
2022
Q4 | $33.2M | Sell |
461,621
-9,474
| -2% | -$714K | 1.81% | 9 |
|
|
2022
Q3 | $33.5M | Sell |
471,095
-1,773
| -0.4% | -$129K | 1.87% | 9 |
|
|
2022
Q2 | $36.4M | Sell |
472,868
-3,024
| -0.6% | -$230K | 1.9% | 9 |
|
|
2022
Q1 | $34.8M | Buy |
475,892
+2,436
| +0.5% | +$164K | 1.55% | 11 |
|
|
2021
Q4 | $29.5M | Sell |
473,456
-18,497
| -4% | -$1.09M | 1.33% | 14 |
|
|
2021
Q3 | $29.1M | Sell |
491,953
-11,364
| -2% | -$748K | 1.33% | 15 |
|
|
2021
Q2 | $33.6M | Buy |
503,317
+1,070
| +0.2% | +$69.8K | 1.49% | 13 |
|
|
2021
Q1 | $31.7M | Sell |
502,247
-10,124
| -2% | -$630K | 1.48% | 12 |
|
|
2020
Q4 | $31.8M | Buy |
+512,371
| New | +$31.5M | 1.57% | 13 |
|
|
2020
Q3 | – | Sell |
-509,601
| Closed | -$30M | – | 392 |
|
|
2020
Q2 | $30M | Buy |
509,601
+1,388
| +0.3% | +$83K | 1.72% | 9 |
|
|
2020
Q1 | $28.3M | Buy |
508,213
+11,218
| +2% | +$686K | 1.91% | 8 |
|
|
2019
Q4 | $31.9M | Buy |
496,995
+102,242
| +26% | +$5.86M | 1.73% | 11 |
|
|
2019
Q3 | $20M | Sell |
394,753
-11,484
| -3% | -$540K | 0.98% | 24 |
|
|
2019
Q2 | $18.4M | Buy |
406,237
+206,048
| +103% | +$9.6M | 0.89% | 27 |
|
|
2019
Q1 | $9.55M | Buy |
200,189
+9,996
| +5% | +$498K | 0.46% | 59 |
|
|
2018
Q4 | $9.89M | Sell |
190,193
-7,394
| -4% | -$397K | 0.52% | 49 |
|
|
2018
Q3 | $12.3M | Sell |
197,587
-743
| -0.4% | -$44.1K | 0.52% | 52 |
|
|
2018
Q2 | $11M | Sell |
198,330
-322
| -0.2% | -$17.4K | 0.51% | 53 |
|
|
2018
Q1 | $12.6M | Buy |
198,652
+3,081
| +2% | +$198K | 0.61% | 42 |
|
|
2017
Q4 | $12M | Buy |
195,571
+225
| +0.1% | +$14.1K | 0.55% | 48 |
|
|
2017
Q3 | $12.5M | Sell |
195,346
-2,917
| -1% | -$170K | 0.65% | 40 |
|
|
2017
Q2 | $11M | Buy |
198,263
+5,910
| +3% | +$322K | 0.6% | 42 |
|
|
2017
Q1 | $10.5M | Buy |
192,353
+7,596
| +4% | +$417K | 0.56% | 45 |
|
|
2016
Q4 | $10.8M | Buy |
184,757
+11,283
| +7% | +$617K | 0.59% | 43 |
|
|
2016
Q3 | $9.35M | Buy |
173,474
+16,125
| +10% | +$1.04M | 0.52% | 45 |
|
|
2016
Q2 | $11.6M | Sell |
157,349
-3,050
| -2% | -$216K | 0.68% | 38 |
|
|
2016
Q1 | $10.2M | Buy |
160,399
+1,500
| +0.9% | +$94.6K | 0.65% | 41 |
|
|
2015
Q4 | $10.9M | Sell |
158,899
-600
| -0.4% | -$39.6K | 0.7% | 38 |
|
|
2015
Q3 | $9.44M | Sell |
159,499
-45
| -0% | -$2.85K | 0.62% | 42 |
|
|
2015
Q2 | $10.6M | Sell |
159,544
-643
| -0.4% | -$42.4K | 0.59% | 40 |
|
|
2015
Q1 | $10.3M | Sell |
160,187
-2,575
| -2% | -$161K | 0.57% | 39 |
|
|
2014
Q4 | $9.61M | Sell |
162,762
-5,029
| -3% | -$284K | 0.56% | 40 |
|
|
2014
Q3 | $8.59M | Buy |
167,791
+795
| +0.5% | +$39.7K | 0.46% | 50 |
|
|
2014
Q2 | $8.1M | Buy |
166,996
+6,982
| +4% | +$344K | 0.4% | 53 |
|
|
2014
Q1 | $8.31M | Sell |
160,014
-25
| -0% | -$1.33K | 0.45% | 49 |
|
|
2013
Q4 | $8.51M | Sell |
160,039
-230
| -0.1% | -$11.7K | 0.47% | 50 |
|
|
2013
Q3 | $7.42M | Sell |
160,269
-145
| -0.1% | -$6.37K | 0.44% | 49 |
|
|
2013
Q2 | $7.17M | Buy |
+160,414
| New | +$6.96M | 0.46% | 50 |
|
Other funds holding BMY
VCM
VPM
Ingalls & Snyder LLC's BMY Position: Q1 2026 in Review
Ingalls & Snyder LLC increased its Bristol-Myers Squibb (BMY) stake by 0.19% in Q1 2026, buying an estimated $8.63K and bringing the position to 78,370 shares worth $4.75M. The position accounts for 0.17% of the portfolio, ranked #102.
Ingalls & Snyder LLC first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $36.4M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Ingalls & Snyder LLC held 78,370 shares of Bristol-Myers Squibb worth $4.75M as of Q1 2026.
- Ingalls & Snyder LLC bought 148 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.63K.
- Bristol-Myers Squibb made up 0.17% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #102 holding.
- Ingalls & Snyder LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Ingalls & Snyder LLC's Bristol-Myers Squibb position peaked at $36.4M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.